Prolonged immunologic and virologic effects of 3TC and zidovudine in subjects who remained on blinded combination therapy beyond 52 weeks in two North American clinical trials
Publication
, Conference
Eron, JJ; Bartlett, JA; Johnson, J; Scott, J; HillPrice, S; Keller, A; Smiley, ML
Published in: AIDS
November 1, 1996
Duke Scholars
Published In
AIDS
ISSN
0269-9370
Publication Date
November 1, 1996
Volume
10
Start / End Page
OP76 / OP76
Publisher
RAPID SCIENCE PUBLISHERS
Related Subject Headings
- Virology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Eron, J. J., Bartlett, J. A., Johnson, J., Scott, J., HillPrice, S., Keller, A., & Smiley, M. L. (1996). Prolonged immunologic and virologic effects of 3TC and zidovudine in subjects who remained on blinded combination therapy beyond 52 weeks in two North American clinical trials. In AIDS (Vol. 10, pp. OP76–OP76). RAPID SCIENCE PUBLISHERS.
Eron, J. J., J. A. Bartlett, J. Johnson, J. Scott, S. HillPrice, A. Keller, and M. L. Smiley. “Prolonged immunologic and virologic effects of 3TC and zidovudine in subjects who remained on blinded combination therapy beyond 52 weeks in two North American clinical trials.” In AIDS, 10:OP76–OP76. RAPID SCIENCE PUBLISHERS, 1996.
Eron JJ, Bartlett JA, Johnson J, Scott J, HillPrice S, Keller A, et al. Prolonged immunologic and virologic effects of 3TC and zidovudine in subjects who remained on blinded combination therapy beyond 52 weeks in two North American clinical trials. In: AIDS. RAPID SCIENCE PUBLISHERS; 1996. p. OP76–OP76.
Eron, J. J., et al. “Prolonged immunologic and virologic effects of 3TC and zidovudine in subjects who remained on blinded combination therapy beyond 52 weeks in two North American clinical trials.” AIDS, vol. 10, RAPID SCIENCE PUBLISHERS, 1996, pp. OP76–OP76.
Eron JJ, Bartlett JA, Johnson J, Scott J, HillPrice S, Keller A, Smiley ML. Prolonged immunologic and virologic effects of 3TC and zidovudine in subjects who remained on blinded combination therapy beyond 52 weeks in two North American clinical trials. AIDS. RAPID SCIENCE PUBLISHERS; 1996. p. OP76–OP76.
Published In
AIDS
ISSN
0269-9370
Publication Date
November 1, 1996
Volume
10
Start / End Page
OP76 / OP76
Publisher
RAPID SCIENCE PUBLISHERS
Related Subject Headings
- Virology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences